PCTC
REGN icon

Perkins Coie Trust Company’s Regeneron Pharmaceuticals REGN Stock Holding History

Perkins Coie Trust Company’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$758 Buy
+1
New +$756 ﹤0.01% 390
2024
Q1 		– Sell
-2
Closed -$1.76K – 290
2023
Q4 		$1.76K Sell
2
-2
-50% -$1.65K ﹤0.01% 232
2023
Q3 		$3.29K Buy
+4
New +$3.14K ﹤0.01% 310

Other funds holding REGN

GA
GuoLine Advisory Singapore $1.16B AUM 31.35% 1-Year Est. Return
AP
Atwood & Palmer Kansas City, Missouri $1.95B AUM 16% 1-Year Est. Return
Fjarde Ap-fonden
Fjarde Ap-fonden Stockholm, Sweden $19.4B AUM 31.69% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return
Wedge Capital Management
Wedge Capital Management Charlotte, North Carolina $5.72B AUM 38.26% 1-Year Est. Return
MN Services Vermogensbeheer
MN Services Vermogensbeheer The Hague, Netherlands $13.4B AUM 37.34% 1-Year Est. Return
Czech National Bank
Czech National Bank Prague, Czech Republic $18.9B AUM 36.24% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $67.3B AUM 21.9% 1-Year Est. Return
IFM Investors
IFM Investors Melbourne, Australia $16B AUM 33.69% 1-Year Est. Return
WC
Woodstock Corp Boston, Massachusetts $1.24B AUM 22.02% 1-Year Est. Return

Perkins Coie Trust Company's REGN Position: Q3 2026 in Review

Perkins Coie Trust Company opened a new position in Regeneron Pharmaceuticals (REGN) in Q3 2026: 1 share worth $758. The stake represents ﹤0.01% of the portfolio and ranks #390 among its holdings. This is a return to the name: Perkins Coie Trust Company previously reported a position in REGN as recently as Q4 2023.

Perkins Coie Trust Company first reported a position in REGN in Q3 2023 and has held it in 3 quarters since. The position peaked at $3.29K in Q3 2023. 151 funds tracked by Wall St. Rank hold REGN as of Q3 2026.

  • Perkins Coie Trust Company held 1 share of Regeneron Pharmaceuticals worth $758 as of Q3 2026.
  • Regeneron Pharmaceuticals was a new Perkins Coie Trust Company position in Q3 2026.
  • Regeneron Pharmaceuticals made up ﹤0.01% of Perkins Coie Trust Company's portfolio in Q3 2026, its #390 holding.
  • Perkins Coie Trust Company first reported a position in Regeneron Pharmaceuticals in Q3 2023 and has held it in 3 quarters since.
  • Perkins Coie Trust Company's Regeneron Pharmaceuticals position peaked at $3.29K in Q3 2023.
  • 151 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q3 2026.

Based on Perkins Coie Trust Company's 13F filing for Q3 2026, filed 15 Oct 2026.